Node-positive Breast Cancer Clinical Trial
Official title:
A Prospective Randomized Trial of Axillary Node Dissection With or Without Lymphaticovenous Bypass (LVB) in Node Positive Breast Cancer Patients
Lymphedema is a devastating complication of breast cancer surgery that decreases the quality of life of up to 40% of breast cancer survivors. Most lymphedema in breast cancer patients is because lymphatics shared between the axilla and the arm are sacrificed during axillary lymph node dissection (ALND) surgery, which removes an average of 15 lymph nodes in node positive patients. CCF's breast cancer plastic microvascular surgeons and breast surgical oncologists have collaborated to refine a surgical technique known as LVB that may be used either as a preventive measure (prophylactic LVB) or as a therapeutic intervention (therapeutic LVB). Lymphatic reconstruction with LVB may be an improvement to the current standard of care for node positive breast cancer patients undergoing ALND.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04039893 -
MUltimodal Targeted Axillary Surgery
|
N/A | |
| Recruiting |
NCT04826211 -
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
|
N/A | |
| Recruiting |
NCT05462457 -
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
|
||
| Recruiting |
NCT05333328 -
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
|
Phase 4 | |
| Not yet recruiting |
NCT05676866 -
Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
|
Phase 4 | |
| Recruiting |
NCT03513614 -
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
|
N/A | |
| Active, not recruiting |
NCT02515110 -
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
|
N/A |